Literature DB >> 10469644

Functional overlap between two classes of matrix-degrading proteases in wound healing.

L R Lund1, J Romer, T H Bugge, B S Nielsen, T L Frandsen, J L Degen, R W Stephens, K Danø.   

Abstract

Retarded wound healing was found in mice deficient in the serine protease precursor plasminogen, as well as in wild-type mice treated with the metalloprotease inhibitor galardin, but in both cases wound closure was ultimately completed in all mice within 60 days. The expression of several matrix metalloproteases in keratinocytes migrating to cover the wound was strongly enhanced by galardin treatment. However, when plasminogen-deficient mice were treated with galardin, healing was completely arrested and wound closure was not seen during an observation period of 100 days, demonstrating that protease activity is essential for skin wound healing. The requirement for both plasminogen deficiency and metalloprotease inhibition for complete inhibition of the healing process indicates that there is a functional overlap between the two classes of matrix-degrading proteases, probably in the dissection of the fibrin-rich provisional matrix by migrating keratinocytes. Each class alone is capable of maintaining sufficient keratinocyte migration to regenerate the epidermal surface, although this function would normally be performed by both classes acting in parallel. Since there are strong similarities between the proteolytic mechanisms in wound healing and cancer invasion, these results predict that complete arrest of this latter process in therapeutic settings will require the use of inhibitors of both classes of proteases.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10469644      PMCID: PMC1171538          DOI: 10.1093/emboj/18.17.4645

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  56 in total

Review 1.  How matrix metalloproteinases regulate cell behavior.

Authors:  M D Sternlicht; Z Werb
Journal:  Annu Rev Cell Dev Biol       Date:  2001       Impact factor: 13.827

Review 2.  Matrix metalloproteinase inhibitors.

Authors:  Nithya Ramnath; Patrick J Creaven
Journal:  Curr Oncol Rep       Date:  2004-03       Impact factor: 5.075

3.  Unimpeded skin carcinogenesis in K14-HPV16 transgenic mice deficient for plasminogen activator inhibitor.

Authors:  Anne Masset; Catherine Maillard; Nor Eddine Sounni; Nathalie Jacobs; Françoise Bruyére; Philippe Delvenne; Marlene Tacke; Thomas Reinheckel; Jean-Michel Foidart; Lisa M Coussens; Agnès Noël
Journal:  Int J Cancer       Date:  2010-03-15       Impact factor: 7.396

4.  Epidermal development and wound healing in matrix metalloproteinase 13-deficient mice.

Authors:  Bettina Hartenstein; Bernd Thilo Dittrich; Dominique Stickens; Babette Heyer; Thiennu H Vu; Sibylle Teurich; Marina Schorpp-Kistner; Zena Werb; Peter Angel
Journal:  J Invest Dermatol       Date:  2006-02       Impact factor: 8.551

Review 5.  Control of matrix metalloproteinase catalytic activity.

Authors:  Hyun-Jeong Ra; William C Parks
Journal:  Matrix Biol       Date:  2007-07-07       Impact factor: 11.583

6.  Matrix metalloproteinases contribute distinct roles in neuroendocrine prostate carcinogenesis, metastasis, and angiogenesis progression.

Authors:  Laurie E Littlepage; Mark D Sternlicht; Nathalie Rougier; Joanna Phillips; Eugenio Gallo; Ying Yu; Kurt Williams; Audrey Brenot; Jeffrey I Gordon; Zena Werb
Journal:  Cancer Res       Date:  2010-03-09       Impact factor: 12.701

7.  Proteins associated with the Myxococcus xanthus extracellular matrix.

Authors:  Patrick D Curtis; James Atwood; Ron Orlando; Lawrence J Shimkets
Journal:  J Bacteriol       Date:  2007-08-31       Impact factor: 3.490

8.  Bone marrow-derived myofibroblasts are the providers of pro-invasive matrix metalloproteinase 13 in primary tumor.

Authors:  Julie Lecomte; Anne Masset; Silvia Blacher; Ludovic Maertens; André Gothot; Marie Delgaudine; Françoise Bruyère; Oriane Carnet; Jenny Paupert; Martin Illemann; Jean-Michel Foidart; Ida K Lund; Gunilla Høyer-Hansen; Agnes Noel
Journal:  Neoplasia       Date:  2012-10       Impact factor: 5.715

9.  Ginsenoside Rb1 Enhances Keratinocyte Migration by a Sphingosine-1-Phosphate-Dependent Mechanism.

Authors:  Kyong-Oh Shin; Sung Jay Choe; Yoshikazu Uchida; Inyong Kim; Yoonhwa Jeong; Kyungho Park
Journal:  J Med Food       Date:  2018-08-27       Impact factor: 2.786

10.  Neutralisation of uPA with a monoclonal antibody reduces plasmin formation and delays skin wound healing in tPA-deficient mice.

Authors:  Annika Jögi; Birgitte Rønø; Ida K Lund; Boye S Nielsen; Michael Ploug; Gunilla Høyer-Hansen; John Rømer; Leif R Lund
Journal:  PLoS One       Date:  2010-09-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.